BioVie Inc
General ticker "BIVI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $17.2M
BioVie Inc does not follow the US Stock Market performance with the rate: -33.3%.
Estimated limits based on current volatility of 6.2%: low 1.89$, high 2.14$
Factors to consider:
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-06-30 to 2026-06-30
- 2024-06-30 to 2025-06-30 estimated range: [1.53$, 5.57$]
- 2025-06-30 to 2026-06-30 estimated range: [1.22$, 4.04$]
Short-term BIVI quotes
Long-term BIVI plot with estimates
Financial data
| YTD | 2024-06-30 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $32.18MM |
| Operating Income | $-32.18MM |
| Non-Operating Income | $0.06MM |
| Interest Expense | $2.89MM |
| R&D Expense | $23.10MM |
| Income(Loss) | $-32.12MM |
| Profit(Loss) | $-32.12MM |
| Stockholders Equity | $15.51MM |
| Assets | $25.21MM |
| Operating Cash Flow | $-27.95MM |
| Investing Cash Flow | $14.53MM |
| Financing Cash Flow | $17.80MM |
| Earnings Per Share* | $-7.30 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.